Dr. Sholl is an associate pathologist at Brigham and Women’s Hospital in Boston and Associate Professor of Pathology at Harvard Medical School. She is board certified in anatomic pathology and molecular genetics pathology with an expertise in neoplastic and non-neoplastic lung diseases. She completed her medical school training at Stanford University School of Medicine, followed by an internship in internal medicine at the Hospital of University of Pennsylvania, AP residency and fellowship training at Brigham and Women’s Hospital, and the molecular genetics pathology fellowship at the Harvard teaching hospitals. She performs clinical and translational research focusing on the molecular mechanisms of tumorigenesis in lung carcinomas, identification of predictive and prognostic molecular markers in tumor and fibrosing lung diseases, and validation of novel molecular and immunohistochemical tests for genetic characterization of lung cancers in clinical practice. Dr. Sholl’s responsibilities include serving as the associate medical director of the Center for Advanced Molecular Diagnostics at Brigham and Women’s Hospital and as Chief of the Pulmonary Pathology Service within the division of Anatomic Pathology. Dr. Sholl has been actively involved with IASLC as a member of WCLC programming committees in 2015, 2020, and 2021 and as the Molecular Pathology working group co-chair on the Pathology Committee.